Target intelligence / Profile preview

TMEM123 divergent transcript (TMEM123-DT)

Target
TMEM123-DT
Molecular classification
Other (non-coding RNA)
01

Overview

TMEM123 divergent transcript (TMEM123-DT) is a non-coding RNA gene annotated in genomic databases as an antisense or divergent transcript relative to the protein-coding gene TMEM123. This transcript does not encode a protein and, to date, lacks evidence as a biologically characterized or therapeutic target. All available mechanistic and disease association data pertains to the TMEM123 protein (also known as Porimin/KCT-3), a plasma membrane glycoprotein involved in immune cell migration and tumor immune surveillance, not to TMEM123-DT[1][2]. The protein-coding gene TMEM123 is sometimes confused with its divergent transcript TMEM123-DT, but all major literature and functional studies to date pertain only to TMEM123, not TMEM123-DT[1][2]. The term "TMEM123-DT" refers to a non-coding RNA, not a conventional therapeutic target (such as a receptor, enzyme, or transporter). TMEM123-DT is not a receptor, enzyme, or other conventional target and is likely included in error when searching for protein/gene therapeutic targets. All functional relevance is for TMEM123, not TMEM123-DT[1][2][3].

Other names
TMEM123-DT

Beyond the preview

Go deeper on TMEM123 divergent transcript (TMEM123-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM123 divergent transcript (TMEM123-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call